Metabolites

2R,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is approved by the Food and agent Administration for use in combination with valsartan for the treatment of patients with heart failure.Form:Oil.

2R,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is approved by the Food and agent Administration for use in combination with valsartan for the treatment of patients with heart failure.Form:Oil.

2R,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is approved by the Food and agent Administration for use in combination with valsartan for the treatment of patients with heart failure.

3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative.Form:Solid.

3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative.Form:Solid.

3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative.Form:Solid.

3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative.

3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative.Form:Solid.

3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative.Form:Solid.

3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative.Form:Solid.

3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative.

3'-Deoxyuridine-5'-triphosphate trisodium (3'-dUTP trisodium) is a nucleotide analogue that inhibits DNA-dependent RNA polymerases I and II . 3'-Deoxyuridine-5'-triphosphate trisodium strongly and competitively inhibits the incorporations of UTP